A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation ...

Immunotherapy has dramatically improved the treatment outcomes of primary lung cancer; however, it sometimes causes a serious ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

This study investigated patients with primary lung cancer who received PET/CT scan, a medical imaging test, and subsequently ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

Blocking a protein that imports lactic acid, a metabolic byproduct of cancer cells, reinvigorated exhausted T cells and led to improved tumor control in mouse models of cancer, according to a new ...

Researchers from the Data Science and Artificial Intelligence Institute (DATAI) at the University of Navarra have developed ...

Summit and Akeso's ivonescimab attracted headlines earlier this year when it was shown to be more effective than anti-PD-1 ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...